Dexcom G6 Observational Study

NACompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

February 21, 2019

Primary Completion Date

March 31, 2020

Study Completion Date

March 31, 2020

Conditions
Diabetes
Interventions
DEVICE

Dexcom G6 CGM - Continues Glucose Monitoring sensor system

A blinded factory-calibrated continues glucose monitoring sensor system Dexcom G6 will be placed shortly after admission. Two CGM devices will be inserted in all patients - one in the abdomen and one in the arm to also assess differences in blood glucose readings between upper extremity and abdominal insertion sites. Information on CGM readings will be collected daily during the hospital stay and after hospital discharge for 10 days using the Dexcom Studio software to download the Dexcom receiver data.

DIAGNOSTIC_TEST

POC BG - Point-of-Care Blood Glucose monitoring

Standard of care - bedside point-of-care (POC) capillary blood glucose (BG) monitoring will be done before meals and bedtime daily during the hospital stay and after hospital discharge for 10 days.

Trial Locations (1)

30322

Emory University, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT03832907 - Dexcom G6 Observational Study | Biotech Hunter | Biotech Hunter